[go: up one dir, main page]

ZA200201135B - Pharmaceutical preparation. - Google Patents

Pharmaceutical preparation. Download PDF

Info

Publication number
ZA200201135B
ZA200201135B ZA200201135A ZA200201135A ZA200201135B ZA 200201135 B ZA200201135 B ZA 200201135B ZA 200201135 A ZA200201135 A ZA 200201135A ZA 200201135 A ZA200201135 A ZA 200201135A ZA 200201135 B ZA200201135 B ZA 200201135B
Authority
ZA
South Africa
Prior art keywords
active substance
pharmaceutical preparation
preparation according
production
chitosan derivative
Prior art date
Application number
ZA200201135A
Other languages
English (en)
Inventor
Hans-Rainer Hoffmann
Bodo Asmussen
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA200201135B publication Critical patent/ZA200201135B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004—Preparation of sols
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004—Preparation of sols
    • B01J13/0039—Post treatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200201135A 1999-08-27 2002-02-11 Pharmaceutical preparation. ZA200201135B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19940794A DE19940794A1 (de) 1999-08-27 1999-08-27 Pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
ZA200201135B true ZA200201135B (en) 2002-08-28

Family

ID=7919871

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200201135A ZA200201135B (en) 1999-08-27 2002-02-11 Pharmaceutical preparation.

Country Status (25)

Country Link
EP (1) EP1206253B1 (zh)
JP (1) JP2003508423A (zh)
KR (1) KR100624499B1 (zh)
CN (1) CN1181815C (zh)
AR (1) AR025392A1 (zh)
AT (1) ATE279180T1 (zh)
AU (1) AU779692B2 (zh)
BR (1) BR0013563A (zh)
CA (1) CA2382359C (zh)
CZ (1) CZ301704B6 (zh)
DE (2) DE19940794A1 (zh)
DK (1) DK1206253T3 (zh)
ES (1) ES2231265T3 (zh)
HK (1) HK1047037B (zh)
HU (1) HU227609B1 (zh)
IL (2) IL148220A0 (zh)
MX (1) MXPA02002048A (zh)
NZ (1) NZ517541A (zh)
PL (1) PL203860B1 (zh)
PT (1) PT1206253E (zh)
RU (1) RU2256440C2 (zh)
TR (1) TR200200520T2 (zh)
TW (1) TWI267384B (zh)
WO (1) WO2001015669A1 (zh)
ZA (1) ZA200201135B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100638041B1 (ko) * 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
KR100767336B1 (ko) * 2006-04-19 2007-10-18 서평원 키틴/키토산계 기능성 유무기 복합물질 및 그 제조방법, 및그러한 복합물질의 용도
US9161901B2 (en) 2008-02-21 2015-10-20 University Of South Florida Nanoparticle targeted drug delivery to the lungs using extra-testicular Sertoli cells
UA90013C2 (ru) 2008-03-19 2010-03-25 Давид Анатолійович Нога Фармацевтическая композиция, содержащая инсулин, и способ его получения
PL220269B1 (pl) 2008-04-21 2015-09-30 Przedsiębiorstwo Produkcji Farmaceutycznej Hasco Lek Spółka Akcyjna Kompozytowy nośnik leków proszkowych, sposób wytwarzania nośnika leków oraz urządzenie do wytwarzania cząstek nośnika kompozytowego
DE102009024542A1 (de) * 2009-06-10 2010-12-16 Arivine Pharma Ag Zusammensetzungen auf Basis von Chitosan-Oligosacchariden

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474989A (en) * 1988-11-11 1995-12-12 Kurita Water Industries, Ltd. Drug composition
DE4132005A1 (de) * 1991-09-26 1993-04-01 Merck Patent Gmbh Kombination enthaltend wachstumsfaktoren und polyelektrolyte
DE4140195C2 (de) * 1991-12-05 1994-10-27 Alfatec Pharma Gmbh Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung
RU2085187C1 (ru) * 1995-11-22 1997-07-27 Исследовательская корпорация МДТ Гель для ухода за кожей и лечения ее заболеваний и композиция для его получения
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
CA2228251A1 (en) * 1996-06-11 1997-12-18 Zonagen, Inc. Chitosan drug delivery system
ES2114502B1 (es) * 1996-07-29 1999-07-01 Univ Santiago Compostela Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.
DE19845246A1 (de) * 1997-12-18 1999-06-24 Henkel Kgaa Vitaminhaltige Zubereitungen
ATE281844T1 (de) * 1998-01-16 2004-11-15 Univ Johns Hopkins Orale verabreichung von nukleinsäure-impstoffen durch partikelkomplexe

Also Published As

Publication number Publication date
HUP0300345A2 (hu) 2003-09-29
DE50008259D1 (de) 2004-11-18
DE19940794A1 (de) 2001-03-01
TR200200520T2 (tr) 2002-06-21
ATE279180T1 (de) 2004-10-15
IL148220A0 (en) 2002-09-12
KR20020031416A (ko) 2002-05-01
CN1181815C (zh) 2004-12-29
RU2256440C2 (ru) 2005-07-20
MXPA02002048A (es) 2002-08-20
ES2231265T3 (es) 2005-05-16
PL354572A1 (en) 2004-01-26
AR025392A1 (es) 2002-11-27
AU779692B2 (en) 2005-02-03
CZ301704B6 (cs) 2010-06-02
BR0013563A (pt) 2002-07-09
IL148220A (en) 2009-05-04
CA2382359A1 (en) 2001-03-08
JP2003508423A (ja) 2003-03-04
HK1047037B (zh) 2005-03-24
KR100624499B1 (ko) 2006-09-18
EP1206253B1 (de) 2004-10-13
CA2382359C (en) 2008-03-18
TWI267384B (en) 2006-12-01
HK1047037A1 (zh) 2003-02-07
HU227609B1 (en) 2011-09-28
DK1206253T3 (da) 2005-01-31
PT1206253E (pt) 2005-02-28
CZ2002653A3 (cs) 2002-05-15
EP1206253A1 (de) 2002-05-22
AU7509400A (en) 2001-03-26
WO2001015669A1 (de) 2001-03-08
HUP0300345A3 (en) 2009-01-28
CN1370065A (zh) 2002-09-18
PL203860B1 (pl) 2009-11-30
NZ517541A (en) 2002-08-28

Similar Documents

Publication Publication Date Title
Esfanjani et al. Biopolymer nano-particles and natural nano-carriers for nano-encapsulation of phenolic compounds
Lankalapalli et al. Polyelectrolyte complexes: A review of their applicability in drug delivery technology
Levis et al. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride
Luo et al. Zein‐based micro‐and nano‐particles for drug and nutrient delivery: A review
Panos et al. New drug delivery systems based on chitosan
Yuan et al. Controlled and extended drug release behavior of chitosan-based nanoparticle carrier
Govender et al. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug
Voigt et al. Novel polyelectrolyte multilayer micro-and nanocapsules as magnetic carriers
JP2003519565A (ja) 重合体多層による固体粒子の鋳型化
JP2006514698A5 (zh)
Skiba et al. Development of a new colloidal drug carrier from chemically-modified cyclodextrins: nanospheres and influence of physicochemical and technological factors on particle size
Wang et al. Spray drying encapsulation of CD-MOF nanocrystals into Eudragit® RS microspheres for sustained drug delivery
Kuchekar et al. Screening of factors using Plackett Burman design in the preparation of capecitabine-loaded nano polymeric micelles
de Matos Fonseca et al. Chitosan microparticles embedded with multi-responsive poly (N-vinylcaprolactam-co-itaconic acid-co-ethylene-glycol dimethacrylate)-based hydrogel nanoparticles as a new carrier for delivery of hydrophobic drugs
WO2018203294A1 (en) A system for the controlled release of active ingredients based on polymeric materials and its use in the nutraceutical field
CA2382359C (en) Pharmaceutical preparation containing nanosol
Sadeh et al. Size optimization of mesoporous β-Cyclodextrin Metal-Organic frameworks as Bio-MOFs
Mehrotra et al. Fabrication of lomustine loaded chitosan nanoparticles by spray drying and in vitro cytostatic activity on human lung cancer cell line L132
Nath et al. Using 5-fluorouracil-encored plga nanoparticles for the treatment of colorectal cancer: The in-vitro characterization and cytotoxicity studies
Joshi et al. Gelatin–rosin gum complex nanoparticles: preparation, characterization and colon targeted delivery of 5-fluorouracil
Chatterjee et al. Synthesis and characterization of chitosan droplet particles by ionic gelation and phase coacervation
Liu et al. Sustained release ziprasidone microparticles prepared by spray drying with Soluplus® and ethyl cellulose to eliminate food effect and enhance bioavailability
Zhu et al. Se-incorporated polycaprolactone spherical polyhedron enhanced vitamin B2 loading and prolonged release for potential application in proliferative skin disorders
Singla et al. Nifedipine loaded chitosan microspheres: characterization of internal structure
Anal et al. Biopolymeric micro-and nanoparticles: preparation, characterization and industrial applications